Alta Partners LLC's Schedule 13G/A Filing for AEON Biopharma, Inc.

Alta Partners LLC filed an amendment to its Schedule 13G for AEON Biopharma, Inc., disclosing ownership of 249,870 shares, which includes 15,500 shares issuable upon exercise of warrants. This represents 2.1% of the company's common stock. The filing indicates that Alta Partners LLC has sole voting and dispositive power over these shares. The amendment, filed under Rule 13d-1(c), certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of influencing the control of the issuer. The filing was signed by Steven Cohen, Managing Member, on October 14, 2025.